Background: Quantification of the dialysis dose is an essential element in the management of chronic hemodialytic treatment. Urea clearance is used as a marker of dialysis adequacy although urea only represents small readily permeable solutes but it has several advantages over other an uremic toxins. Several factors affect clearance and include the blood flow rate; the dialysate flow rate and the efficiency of the dialyzer. Other indicators of dialysis adequacy include the removal of large solutes as creаtinine, vitamin B12 and B2 microglobulin and control of the extracellular volume and blood pressure. Adequacy of dialysis should be assessed in all patients at least 3 monthly as clinically based assessment has proven unreliable. Objectives: The aim of this study is to assess hemodialysis adequacy and factors affecting it in pediatric patients in pediatric nephrodialysis unit in Zagazig University. Methods: This study was carried out in pediatric nephrodialysis unit in Zagazig University. It included 30 patients with chronic renal failure on regular hemodialysis. The studied group included 18 females and 12 males. Their ages ranged from 6 to 20 years. They were regularly hemodialysed 3 times weekly and 2 to 4 hours per session by polysulfone membrane using citrate dialysate and their pump rate ranged from 180 to 200 ml/minute. All of them had arteriovenous fistulae. All cases were subjected to detailed history taking, thorough clinical examination and laboratory investigations. Blood urea level pre and post dialysis session using urease colorimetric method was done. Assessment of single pool KdV using the following equation: Kt/V = 2.2 -3.3 X (u post/u pre -0.03 -(w pre -w post)/w post). Results: We found a significant positive correlation between Kt/V and pump rate, surface area of the dialyzer and duration of dialysis. A highly significant positive correlation was found between Kt/V and dialysis session length and also with serum albumin. No significant correlation was found between Kt/V and other laboratory parameters or blood pressure. The most effective parameter affecting the dialysis efficiency is the dialysis session length. Conclusion: We conclude that adequate dialysis maximizes well-being, minimizing morbidity, and helps a patient retain social independence. Dialysis prescription should be individualized, monitored, and reassessed regularly. Improving dialysis adequacy as indicated by increased Kt/V can be achieved by increasing dialysis session length, pump rate and the size of the dialyzer.
INTRODUCTION
With dialysis and renal transplantation as long-term renal replacement therapy (RRT), the prognosis of end stage renal failure in children has been completely changed ( I ). The main aims of dialysis treatment are to prolong _patient survival, reduce morbidity and improve quality of lіfet 2) . Since inadequate dialysis increases mortality and morbidity of patients, therefore, assessment of dialysis adequacy is clinically іmportantt 3) . Adequate delivered dose of solute removal is assessed by urea reduction and calculation of KtN. The most useful and widely applied index to prescribe the dialysis dose (as well as to assess the dose which is actually delivered) is the КtN (4) . Urea reduction ratio (URR) continues to be viable but with pitfalls.
Although URR correlates well with spKtN in population studies, significant variability in correlation in individual patients occurs because URR fails to include both the contraction in extracellular volume (ECV) and the urea generation that typically occur during routine hemodialysis (HD) (5) . The urea reduction ratio (URR) is calculated from the difference in the blood urea concentration before and after dialysis divided by the pre-dialysis blood urea concentratіont 6) . Delivered HD dose (Kt/V) value is calculated by various formulae utilizing pre-and postdialysis blood urea concentrations. The Kt/V value represents dialyzer clearance (K) distribution volume of urea (V) and dialysis duration (t) (7 . Current guidelines suggest a minimum Kt/V of 1.2 for three weekly hemodialysis sessіons (^) . U pre = pre-dialysis urea.
AIM OF THIS STUDY
U post = post-dialysis urea. W pre = pre-dialysis weight. W post post-dialysis weight.
-The predialysis and postdialysis samples must be drawn at the same dialysis session.
-The predialysis urea blood sample was obtained from the arterial needle before administering any saline or heparin. -The postdialysis urea blood sample was obtained at the end of the dialysis session by slowing the blood pump to 50-100 ml/ min for 10-20 sec, after which the blood pump was stopped and a blood sample was obtained either from the arterial bloodline sampling port or from the tubing attached to the arterial needle. The postdialysis urea blood sample must not be diluted by either recirculation or saline.
Statistical analysis of the data: Data were analyzed with statistical program "SPSS" under windows v. 6.21.
RESULTS
Our results are shown in Tables 1 to 15 and Figures 1 to 6 . Table 1 shows the characteristic data of the studied group as regard age and gender. The etiology of chronic renal failure in the studied group was shown in Table 2 and Figure 1 . The most common cause is unknown (36.3%), followed by chronic familial interstitial nephritis (13.3%) and focal segmental glomerulosclerosis (10%). Table 3 shows the laboratory parameters in the studied group. Duration of dialysis, hemodialysis session length, pump rate, dialyzer surface area and Kt/V in the studied group are presented in Tables 4. 5, 6, 7 and 8 respectively.
There was a significant positive correlation between Kt/V and pump rate, surface area of the dialyzer and duration of the dialysis as shown in Tables 9, 10 and 11. Table 12 shows highly significant positive correlation between Kt/V and dialysis session length. Also there wаs highly significant positive correlation between Kt/V and serum albumin as shown in Table 13 and Figure 2 . No significant correlation was found between Kt/V and other laboratory parameters or blood pressure as presented in Tables 13 and 14 respectiv ely. The most effective parameter affecting the dialysis efficiency is the dialysis session length as shown in Table 15 .
DISCUSSION
Adequate hemodialysis can be defined as the amount of dialysis required for optimal patient survival ( 10) . . In our study, we found significant positive correlation between ' pump flow rate and Kt/V and this may he explained by increase flow rate leads to increase filtration and removal of small molecular weight solutes. The above result was found also in the study done by I lassell et al., 2001 even in patients with low access flow, increasing dialyzer blood flow rate in general leads to an increase in delivered Kt/V regardless of vascular access flow rate (`°) . Also our result run with the studies done by Borzou et al., 2009 and Kim et al., 2004 who confirmed that increa-sing the blood flow rate by 25% is effective in increasing dialysis adequacy and increasing blood flow rate by 15-20% of previous flow rate is effective in achieving dialysis adequacy in hemodialysis patients with low Kt/V respectively`' 1 "-). Our study showed significant positive correlation between duration of dialysis session and Kt/V and this may be explained by increased time of contact between blood and dialysate will remove a higher percentage of waste products. Patients with longer hemodialysis treatments have fewer complications secondary to ultrafiltration and thus are more likely to routinely achieve their estimated dry weight. As a result, they suffer fewer cardiovascular complications secondary to hypertension and/or hypervolemia. Saran. et al.. 2006 found the same result of longer dialysis session duration may be beneficial in several ways; improved tolerability of the treatment, greater removal of uremic toxins, particularly middle molecules, better control of blood pressure, and better volume management. These mechanisms may in turn reduce cardiovascular morbidity and mortaljty (23) . Longer treatment time is utilized in clinical practice as one of the methods to increase delivered KtIV which is confirmed by Marshall et al., 2006 who examine associations between HD dose and session length with mortality risk and support the inclusion of criteria relating to session length in definitions of adequate HD practісе 24 '. As all our patients attended 3
sessions per week, we could not assess the effect of frequency of dialysis on Kt/V but some studies showed improved Kt/V with increased frequency of dialysis. Zucchclli et al., 2005 , found that daily HD leads to improve dialysis outcome. The basis for the beneficial effect is thought to be a more physiological clearance of solutes and water, with reduced pre-and post-I TI) solute concentration''' ) . Chazot and Jean, 2009. found the positive effects of prolonged dialysis time or increased dialysis frequency lead to improvement of patients survival'2
6)
As regards correlation between surface area of dialyzer and Kt/V we found positive correlation. This may be explained by increase filtration and removal of small molecular weight solutes from blood through membrane with more surface area. Azar, 2009, found that low flux and small surface area dialyzer did not show an improvement in Kt/V or URR with increase in dialysate flow rate t2 " and another study done by Barth. 1996 , showed that reducing treatment time will not affect the patient well-being if the dialyzer surface area inereased (28) . In our study, we found significant positive correlation between duration of dialysis and dialysis adequacy. It may be explained as the duration of dialysis prolonged the patient become more adapted and tolerated to dialysis regimen and dietary control that decrease urea production which is the same found by Rocco et al., 2001 (29) .
We used in this study low flux dialyzer because it is the only available in our hemodialysis unit. The study done by Locatelli. Cavalli and Tucci, 2009, showed no significant difference between high-flux and low-flux membranes (30) . The effect of high-flux hemodialysis membranes on patient survival has not been unequivocally determined. However, the effect of high-flux membrane showed a significant survival benefit in patients at risk for worse 
